chr6:36790067-36843736 |
chr6:36790666 |
rs9366917 |
CPNE5 |
Coronary heart disease |
intron |
0.000153 |
GWASdb |
chr6:36790067-36843736 |
chr6:36790666 |
rs9366917 |
CPNE5 |
Acute lung injury |
intron |
0.000493 |
GWASdb |
chr6:36790067-36843736 |
chr6:36791835 |
rs236375 |
CPNE5 |
Lymphocyte counts |
intron |
0.000558 |
GWASdb |
chr6:36790067-36843736 |
chr6:36792006 |
rs236374 |
CPNE5 |
Acute lung injury |
intron |
0.000283 |
GWASdb |
chr6:36790067-36843736 |
chr6:36792057 |
rs236373 |
CPNE5 |
Acute lung injury |
intron |
0.00056 |
GWASdb |
chr6:36790067-36843736 |
chr6:36792057 |
rs236373 |
CPNE5 |
Heart rate |
intron |
9e-07 |
GWASdb |
chr6:36790067-36843736 |
chr6:36814105 |
rs9368965 |
NA |
Cognitive test performance |
NA |
7.02e-05 |
GWASdb |
chr6:36790067-36843736 |
chr6:36819210 |
rs9380614 |
NA |
Cognitive test performance |
NA |
4.57e-05 |
GWASdb |
chr6:36790067-36843736 |
chr6:36824281 |
rs236373 |
CPNE5 |
Heart rate |
intron_variant |
9e-07 |
GWAS_Catalog |
chr6:36777969-36829564 |
chr6:36790666 |
rs9366917 |
CPNE5 |
Coronary heart disease |
intron |
0.000153 |
GWASdb |
chr6:36777969-36829564 |
chr6:36790666 |
rs9366917 |
CPNE5 |
Acute lung injury |
intron |
0.000493 |
GWASdb |
chr6:36777969-36829564 |
chr6:36791835 |
rs236375 |
CPNE5 |
Lymphocyte counts |
intron |
0.000558 |
GWASdb |
chr6:36777969-36829564 |
chr6:36792006 |
rs236374 |
CPNE5 |
Acute lung injury |
intron |
0.000283 |
GWASdb |
chr6:36777969-36829564 |
chr6:36792057 |
rs236373 |
CPNE5 |
Acute lung injury |
intron |
0.00056 |
GWASdb |
chr6:36777969-36829564 |
chr6:36792057 |
rs236373 |
CPNE5 |
Heart rate |
intron |
9e-07 |
GWASdb |
chr6:36777969-36829564 |
chr6:36814105 |
rs9368965 |
NA |
Cognitive test performance |
NA |
7.02e-05 |
GWASdb |
chr6:36777969-36829564 |
chr6:36819210 |
rs9380614 |
NA |
Cognitive test performance |
NA |
4.57e-05 |
GWASdb |
chr6:36777969-36829564 |
chr6:36824281 |
rs236373 |
CPNE5 |
Heart rate |
intron_variant |
9e-07 |
GWAS_Catalog |
chr6:36869506-36888367 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36869506-36888367 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36869506-36888367 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36869506-36888367 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36869506-36888367 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36871182-36882919 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36871182-36882919 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36871182-36882919 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36871182-36882919 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36871182-36882919 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36852719-36893907 |
chr6:36853543 |
rs9380618 |
NA |
Breast cancer |
NA |
2.01e-05 |
GWASdb |
chr6:36852719-36893907 |
chr6:36855382 |
rs9357230 |
C6orf89 |
Response to taxane treatment (placlitaxel) |
intron |
0.000432 |
GWASdb |
chr6:36852719-36893907 |
chr6:36867372 |
rs140986907 |
C6orf89 |
Breast cancer |
missense |
0.00052 |
GWASdb |
chr6:36852719-36893907 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36852719-36893907 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36852719-36893907 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36852719-36893907 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36852719-36893907 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36852719-36893907 |
chr6:36852789 |
rs236349 |
C6orf89 |
Resting heart rate |
downstream_gene_variant |
1e-15 |
GWAS_Catalog |
chr6:36875716-36907293 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36875716-36907293 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36852970-36892580 |
chr6:36853543 |
rs9380618 |
NA |
Breast cancer |
NA |
2.01e-05 |
GWASdb |
chr6:36852970-36892580 |
chr6:36855382 |
rs9357230 |
C6orf89 |
Response to taxane treatment (placlitaxel) |
intron |
0.000432 |
GWASdb |
chr6:36852970-36892580 |
chr6:36867372 |
rs140986907 |
C6orf89 |
Breast cancer |
missense |
0.00052 |
GWASdb |
chr6:36852970-36892580 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36852970-36892580 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36852970-36892580 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36852970-36892580 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36852970-36892580 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36852719-36894315 |
chr6:36853543 |
rs9380618 |
NA |
Breast cancer |
NA |
2.01e-05 |
GWASdb |
chr6:36852719-36894315 |
chr6:36855382 |
rs9357230 |
C6orf89 |
Response to taxane treatment (placlitaxel) |
intron |
0.000432 |
GWASdb |
chr6:36852719-36894315 |
chr6:36867372 |
rs140986907 |
C6orf89 |
Breast cancer |
missense |
0.00052 |
GWASdb |
chr6:36852719-36894315 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36852719-36894315 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36852719-36894315 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36852719-36894315 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36852719-36894315 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36852719-36894315 |
chr6:36852789 |
rs236349 |
C6orf89 |
Resting heart rate |
downstream_gene_variant |
1e-15 |
GWAS_Catalog |
chr6:36852665-36893955 |
chr6:36853543 |
rs9380618 |
NA |
Breast cancer |
NA |
2.01e-05 |
GWASdb |
chr6:36852665-36893955 |
chr6:36855382 |
rs9357230 |
C6orf89 |
Response to taxane treatment (placlitaxel) |
intron |
0.000432 |
GWASdb |
chr6:36852665-36893955 |
chr6:36867372 |
rs140986907 |
C6orf89 |
Breast cancer |
missense |
0.00052 |
GWASdb |
chr6:36852665-36893955 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36852665-36893955 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36852665-36893955 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36852665-36893955 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36852665-36893955 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36852665-36893955 |
chr6:36852789 |
rs236349 |
C6orf89 |
Resting heart rate |
downstream_gene_variant |
1e-15 |
GWAS_Catalog |
chr6:36840724-36894134 |
chr6:36853543 |
rs9380618 |
NA |
Breast cancer |
NA |
2.01e-05 |
GWASdb |
chr6:36840724-36894134 |
chr6:36855382 |
rs9357230 |
C6orf89 |
Response to taxane treatment (placlitaxel) |
intron |
0.000432 |
GWASdb |
chr6:36840724-36894134 |
chr6:36867372 |
rs140986907 |
C6orf89 |
Breast cancer |
missense |
0.00052 |
GWASdb |
chr6:36840724-36894134 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36840724-36894134 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36840724-36894134 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36840724-36894134 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36840724-36894134 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36840724-36894134 |
chr6:36852789 |
rs236349 |
C6orf89 |
Resting heart rate |
downstream_gene_variant |
1e-15 |
GWAS_Catalog |
chr6:36840684-36893529 |
chr6:36853543 |
rs9380618 |
NA |
Breast cancer |
NA |
2.01e-05 |
GWASdb |
chr6:36840684-36893529 |
chr6:36855382 |
rs9357230 |
C6orf89 |
Response to taxane treatment (placlitaxel) |
intron |
0.000432 |
GWASdb |
chr6:36840684-36893529 |
chr6:36867372 |
rs140986907 |
C6orf89 |
Breast cancer |
missense |
0.00052 |
GWASdb |
chr6:36840684-36893529 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36840684-36893529 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36840684-36893529 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36840684-36893529 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36840684-36893529 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36840684-36893529 |
chr6:36852789 |
rs236349 |
C6orf89 |
Resting heart rate |
downstream_gene_variant |
1e-15 |
GWAS_Catalog |
chr6:36840716-36894233 |
chr6:36853543 |
rs9380618 |
NA |
Breast cancer |
NA |
2.01e-05 |
GWASdb |
chr6:36840716-36894233 |
chr6:36855382 |
rs9357230 |
C6orf89 |
Response to taxane treatment (placlitaxel) |
intron |
0.000432 |
GWASdb |
chr6:36840716-36894233 |
chr6:36867372 |
rs140986907 |
C6orf89 |
Breast cancer |
missense |
0.00052 |
GWASdb |
chr6:36840716-36894233 |
chr6:36871931 |
rs6931297 |
C6orf89 |
Prostate cancer |
intron |
1e-04 |
GWASdb |
chr6:36840716-36894233 |
chr6:36872657 |
rs6932579 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36840716-36894233 |
chr6:36873787 |
rs1224499 |
C6orf89 |
Multiple complex diseases |
intron |
0.000843 |
GWASdb |
chr6:36840716-36894233 |
chr6:36875883 |
rs9462242 |
C6orf89 |
Prostate cancer |
intron |
6e-05 |
GWASdb |
chr6:36840716-36894233 |
chr6:36879464 |
rs6900068 |
C6orf89 |
Cognitive test performance |
intron |
1.68e-05 |
GWASdb |
chr6:36840716-36894233 |
chr6:36852789 |
rs236349 |
C6orf89 |
Resting heart rate |
downstream_gene_variant |
1e-15 |
GWAS_Catalog |
chr6:36840633-36856056 |
chr6:36853543 |
rs9380618 |
NA |
Breast cancer |
NA |
2.01e-05 |
GWASdb |
chr6:36840633-36856056 |
chr6:36855382 |
rs9357230 |
C6orf89 |
Response to taxane treatment (placlitaxel) |
intron |
0.000432 |
GWASdb |
chr6:36840633-36856056 |
chr6:36852789 |
rs236349 |
C6orf89 |
Resting heart rate |
downstream_gene_variant |
1e-15 |
GWAS_Catalog |